Oh Heung-joo, President of Dongkook Pharmaceutical, Promoted to General President

Vice Presidents Jeon Se-il and Lee Jong-jin Appointed as Acting Presidents

Oh Heung-joo, President of Dongkook Pharmaceutical (Photo by Dongkook Pharmaceutical)

[Asia Economy Reporter Kim Ji-hee] Dongkook Pharmaceutical announced on the 29th that it has carried out executive personnel changes effective April 1, 2021. President Oh Heung-joo was promoted to General President, and Vice Presidents Jeon Se-il and Lee Jong-jin were elevated to President-equivalent positions.

The newly appointed General President Oh graduated from the College of Pharmacy at Seoul National University and joined Dongkook Pharmaceutical in 1989. He served as Vice President of the Overseas Business Division from 2008, was appointed CEO in 2009, and currently serves as Vice Chairman of the Ethics Committee of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.

President-equivalent Jeon Se-il graduated from the Department of Sociology at Kyungpook National University and held key positions in ETC sales and marketing at CJ from 1988 to 2006. He moved to Dongkook Pharmaceutical in 2007 and served as Vice President in charge of Sales and Marketing from 2017.

President-equivalent Lee Jong-jin graduated from Northumbria University in the UK with a degree in International Business and completed an MBA at the University of London. After working at LG Electronics, he joined Dongkook Pharmaceutical in 2014.

This content was produced with the assistance of AI translation services.